✦ LIBER ✦

Consensus statement: Botulinum toxin in myofacial pain

✍ Scribed by Peter Reilich; Klemens Fheodoroff; Uwe Kern; Siegfried Mense; Susann Seddigh; Jörg Wissel; Dieter Pongratz

Publisher: Springer
Year: 2004
Tongue: English
Weight: 112 KB
Volume: 251
Category: Article
ISSN: 0340-5354
DOI: 10.1007/s00415-004-1109-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Botulinum toxin in rare pain syndromes

✍ M. Naumann; B. Eberhardt; R. Laskawi; M. Porta; P. Schnider; P. Sostak; M. Lutze 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 132 KB

Botulinum toxin type A in experimental n

Botulinum toxin type A in experimental neuropathic pain

✍ L. Bach-Rojecky; M. Relja; Z. Lacković 📂 Article 📅 2005 🏛 Springer 🌐 English ⚖ 99 KB

Neurobiological basis for the use of bot

Neurobiological basis for the use of botulinum toxin in pain therapy

✍ S. Mense 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 476 KB

“Off” painful dystonia in Parkinson's di

“Off” painful dystonia in Parkinson's disease treated with botulinum toxin

✍ Dr. C. Pacchetti; G. Albani; E. Martignoni; L. Godi; E. Alfonsi; G. Nappi 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 369 KB

The "off' painful dystonia (OPD), usually concerning the feet, is a type of abnormal involuntary movement, induced by the chronic use of levodopa. It is mostly observed in the advanced stage of Parkinson's disease (PD), particularly in the early morning, in the evening, and late at night. Indeed, so

Botulinum toxin type a induces direct an

Botulinum toxin type a induces direct analgesic effects in chronic neuropathic pain

✍ Danièle Ranoux; Nadine Attal; Francoise Morain; D. Bouhassira 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 731 KB

Evidence based medicine in the use of bo

Evidence based medicine in the use of botulinum toxin for back pain

✍ B. Jabbari 📂 Article 📅 2008 🏛 Springer 🌐 English ⚖ 177 KB